Artículos de revistas
Alprostadil associated with low molecular weight heparin to treat limb ischemia caused by SARS-CoV2
Alprostadil associado a heparina de baixo peso molecular para o tratamento da isquemia de membros causada por SARS-CoV2
Fecha
2020-01-01Registro en:
Jornal Vascular Brasileiro, v. 19, p. 1-7.
1677-7301
1677-5449
10.1590/1677-5449.200072
S1677-54492020000100623
2-s2.0-85097958387
S1677-54492020000100623.pdf
Autor
Pontifícia Universidade Católica de São Paulo – PUC-SP
Conjunto Hospitalar de Sorocaba
Cirurgia Vascular e Endovascular
Universidade Vila Velha – UVV
Universidade Estadual Paulista (Unesp)
JJMED
Institución
Resumen
The current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19.